Olivotto I - Search Results

1

Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions.

Girolami F, Gozzini A, Pálinkás ED, Ballerini A, Tomberli A, Baldini K, Marchi A, Zampieri M, Passantino S, Porcedda G, Calabri GB, Bennati E, Spaziani G, Crotti L, Cecchi F, Favilli S, Olivotto I. Girolami F, et al. Among authors: olivotto i. J Clin Med. 2023 Mar 24;12(7):2489. doi: 10.3390/jcm12072489. J Clin Med. 2023. PMID: 37048573 Free PMC article.

2

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. J Am Coll Cardiol. 1995 Nov 15;26(6):1529-36. doi: 10.1016/0735-1097(95)00353-3. J Am Coll Cardiol. 1995. PMID: 7594081 Free article.

3

Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration.

Cecchi F, Montereggi A, Olivotto I, Marconi P, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. Heart. 1997 Jul;78(1):44-9. doi: 10.1136/hrt.78.1.44. Heart. 1997. PMID: 9290401 Free PMC article.

4

[Clinical course of hypertrophic cardiomyopathy in a non selected population. The Experience of the Italian Multicenter Cardiomyopathy Study].

Cecchi F, Olivotto I, Lazzeroni E, Chiriatti G, Sachero A, Beretta L, Giagnoni E, Renosto G, Montereggi A, Baldassarre S, Castelli G, Ciaccheri M. Cecchi F, et al. Among authors: olivotto i. G Ital Cardiol. 1997 Nov;27(11):1133-43. G Ital Cardiol. 1997. PMID: 9463057 Italian.

5

Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.

Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Cecchi F, et al. Among authors: olivotto i. Heart. 1998 Apr;79(4):331-6. doi: 10.1136/hrt.79.4.331. Heart. 1998. PMID: 9616338 Free PMC article.

6

Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.

Olivotto I, Montereggi A, Mazzuoli F, Cecchi F. Olivotto I, et al. G Ital Cardiol. 1999 Jan;29(1):11-9. G Ital Cardiol. 1999. PMID: 9987042

7

Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Olivotto I, et al. J Am Coll Cardiol. 1999 Jun;33(7):2044-51. doi: 10.1016/s0735-1097(99)00094-7. J Am Coll Cardiol. 1999. PMID: 10362212 Free article.

8

[Therapy of hypertrophic cardiomyopathy].

Cecchi F, Olivotto I. Cecchi F, et al. Among authors: olivotto i. G Ital Cardiol. 1999 Oct;29(10):1199-203. G Ital Cardiol. 1999. PMID: 10546134 Italian. No abstract available.

9

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Cecchi F. Olivotto I, et al. Curr Cardiol Rep. 2001 Mar;3(2):141-6. doi: 10.1007/s11886-001-0041-x. Curr Cardiol Rep. 2001. PMID: 11177672 Review.

10

Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.

Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Olivotto I, et al. Circulation. 2001 Nov 20;104(21):2517-24. doi: 10.1161/hc4601.097997. Circulation. 2001. PMID: 11714644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

753 results

Search Page